Kaishan Tao
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology top 5%
- Surgery top 10%
- Hepatology top 2%
- Topics
- Liver physiology and pathology (16 papers)MicroRNA in disease regulation (16 papers)Organ Transplantation Techniques and Outcomes (16 papers)
- Cited by
- Cancer ResearchHepatologyOncology
- Journals
- SHILAP Revista de lepidopterologíaNano LettersPLoS ONE
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Kaishan Tao
102 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Molecular Biology 1.5k
- Cancer Research 921
- Oncology 646
- Surgery 472
- Hepatology 422
Countries citing papers authored by Kaishan Tao
This map shows the geographic impact of Kaishan Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaishan Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaishan Tao more than expected).
Fields of papers citing papers by Kaishan Tao
This network shows the impact of papers produced by Kaishan Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaishan Tao. The network helps show where Kaishan Tao may publish in the future.
Co-authorship network of co-authors of Kaishan Tao
This figure shows the co-authorship network connecting the top 25 collaborators of Kaishan Tao. A scholar is included among the top collaborators of Kaishan Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaishan Tao. Kaishan Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADDbreakdown → | 60 |
| 5 | 2 | |
| 6 | 19 | |
| 7 | 4 | |
| 8 | 60 | |
| 9 | 8 | |
| 10 | [Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells]. | 3 |
| 11 | 0 | |
| 12 | 34 | |
| 13 | 1 | |
| 14 | Pig Liver Xenotransplantation: A Review of Progress Toward the Clinic | 5 |
| 15 | 2 | |
| 16 | 8 | |
| 17 | 22 | |
| 18 | 26 | |
| 19 | 19 | |
| 20 | 17 |
About Kaishan Tao
Kaishan Tao is a scholar working on Hepatology, Cancer Research and Transplantation, having authored 108 papers that have together received 2.9k indexed citations. Recurring topics across this work include Liver physiology and pathology (16 papers), MicroRNA in disease regulation (16 papers) and Organ Transplantation Techniques and Outcomes (16 papers). The work is most often cited by research in Cancer Research (921 citations), Hepatology (422 citations) and Oncology (646 citations). Kaishan Tao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Kefeng Dou, Dou Ke-feng, Nan You, Wenjie Song, Bai Ruan, Zhuochao Zhang, Xisheng Yang, Zhao-Xu Yang, Qike Huang and Weihui Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, Nano Letters and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.